OVA1 measures the serum levels of five analytes, CA125, transthyretin, apolipoprotein A1, transferrin, and β2M. Results are reported as high or low risk for ovarian cancer and are used to determine whether referral to gynecologic oncology is required prior to surgical treatment of an adnexal mass. Here, B2M is linked to ovarian cancer.